PINTAIL LTD

Their core work

Pintail is an Irish SME that provides specialized data management, health economics analysis, regulatory compliance, and project coordination services to European health research consortia. They embed within large clinical and translational research projects — particularly in cell therapy, cancer survivorship, and medical device development — delivering the analytical and operational backbone that helps research teams navigate from lab discoveries to clinical validation. Their sole coordinated project (PORSAV) focused on controlling viral aerosols in surgical settings, revealing in-house expertise in medical safety engineering alongside their consultancy work.

What they specialise in

How they've shifted over time

In 2015–2018, Pintail focused heavily on clinical-stage cell therapies — supporting trials for mesenchymal stromal cells in kidney disease (NEPHSTROM), osteoarthritis (ADIPOA2), and automated stem cell manufacturing (AUTOSTEM), alongside materials discovery (NoMaD). From 2019 onward, their work shifted toward automated GMP-compliant cell manufacturing (AutoCRAT), digital survivorship care platforms (PanCareSurPass), mental health interventions (MENTUPP), and pandemic-related safety engineering (PORSAV, PANDEM-2). The clear trajectory is from supporting individual clinical trials toward broader health system challenges — manufacturing scale-up, digital health infrastructure, and public health preparedness.

Pintail is moving from clinical trial support toward health technology scale-up, automated biomanufacturing compliance, and digital health systems — positioning them for the translational gap between research and regulated products.

How they like to work

Pintail operates almost exclusively as a consortium partner (15 of 16 projects), contributing specialist services rather than leading research direction. With 171 unique partners across 25 countries, they function as a highly networked service provider that plugs into diverse consortia rather than building repeated partnerships with the same groups. This makes them an adaptable, low-friction partner experienced in fitting into large multidisciplinary teams — useful for coordinators who need reliable operational support without political complexity.

Pintail has collaborated with 171 distinct partners across 25 countries, giving them one of the broadest partner networks for an Irish health SME. Their connections span major European clinical research hubs, with no single geographic cluster dominating — a truly pan-European reach.

What sets them apart

Pintail occupies a rare niche: a small Irish company that combines health economics expertise, regulatory knowledge (GMP/GAMP), and data management under one roof, specifically tailored for translational health research projects. Unlike academic partners who contribute scientific knowledge or large CROs who handle trial logistics, Pintail provides the analytical and compliance layer that helps research consortia demonstrate real-world value and regulatory readiness. Their PORSAV coordination also shows they can lead focused innovation projects, not just support others.

Highlights from their portfolio

• PORSAV
  Pintail's only coordinated project — developed viral aerosol control technology for operating rooms during COVID-19, showing independent innovation capacity beyond their consultancy role.
• AutoCRAT
  Addresses the critical bottleneck of automated, GMP-compliant stem cell manufacturing for osteoarthritis — directly at the translational frontier where Pintail's regulatory expertise is most valuable.
• PANDEM-2
  Pandemic preparedness simulation and surveillance platform — represents Pintail's expansion into public health systems beyond their traditional clinical trial support.